Word

GLOSUNVY

Status

Pending

Status Code

731

Status Date

Wednesday, February 7, 2024

Serial Number

97595372

Mark Type

4000

Filing Date

Friday, September 16, 2022

Published for Opposition

Tuesday, January 31, 2023

Trademark Owner History

Gilead Sciences Ireland UC - Owner At Publication

Classifications

5 Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

The wording "GLOSUNVY" has no meaning in a foreign language.

Trademark Events

Feb 9, 2024

Notice Of Approval Of Extension Request E-Mailed

Feb 7, 2024

Sou Extension 2 Granted

Feb 7, 2024

Sou Extension 2 Filed

Feb 7, 2024

Sou Teas Extension Received

Aug 4, 2023

Notice Of Approval Of Extension Request E-Mailed

Aug 2, 2023

Sou Extension 1 Granted

Aug 2, 2023

Sou Extension 1 Filed

Aug 2, 2023

Sou Teas Extension Received

Mar 28, 2023

Noa E-Mailed - Sou Required From Applicant

Jan 31, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 31, 2023

Published For Opposition

Jan 11, 2023

Notification Of Notice Of Publication E-Mailed

Dec 28, 2022

Electronic Record Review Complete

Dec 23, 2022

On Hold - Electronic Record Review Required

Dec 20, 2022

Approved For Pub - Principal Register

Dec 20, 2022

Examiner's Amendment Entered

Dec 20, 2022

Notification Of Examiners Amendment E-Mailed

Dec 20, 2022

Examiners Amendment E-Mailed

Dec 20, 2022

Examiners Amendment -Written

Dec 12, 2022

Assigned To Examiner

Oct 3, 2022

New Application Office Supplied Data Entered

Sep 20, 2022

New Application Entered